Associated Papers
Structure of the core human NADPH oxidase NOX2.
Noreng S et al.
Nature Communications, 2022
36241643 (PubMed )
Supplement: 41467_2022_33711_MOESM1_ESM.pdf
Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.
Rawat A et al.
Frontiers in Immunology, 2021
Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM et al.
Bmc Medical Genomics, 2019
31345222 (PubMed )
Supplement: 12920_2019_543_MOESM6_ESM.xlsx › S5C
[Clinical features of chronic granulomatous disease].
Ying WJ et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 2012
Role of putative second transmembrane region of Nox2 protein in the structural stability and electron transfer of the phagocytic NADPH oxidase.
Picciocchi A et al.
The Journal of Biological Chemistry, 2011
Genetics and immunopathology of chronic granulomatous disease.
Stasia MJ et al.
Seminars in Immunopathology, 2008
[The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation].
Stasia MJ
Medecine Sciences : M/s, 2007
[Chronic granulomatous disease (CGD)].
Takikawa K et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine, 1977
Select a paper to view details